London, March 18, 2026, 20:47 GMT
Schroders ticked up 0.17% to close at 573p on Wednesday, remaining under the 590p cash offer Nuveen has on the table. The British asset manager’s sale stayed in the spotlight after new takeover-code disclosures surfaced, including a Vanguard filing that revealed a 2.53% stake in Schroders. 1
The gap’s not trivial: those watching the deal now turn to milestones laid out in the scheme document released last week. Court and general meetings are set for April 16, with the takeover slated to complete sometime in the fourth quarter—pending shareholder votes, court sanction, and regulatory sign-off. If it does go through, Schroders’ London listing is set to disappear. 2
The deal is moving forward via a scheme of arrangement—a UK court-sanctioned approach designed to secure 100% control if all nods come through. On Wednesday, UK Takeover Code filings featured a dealing notice from BNP Paribas relating to Pantheon, the entity Nuveen has set up for its offer. 2
Schroders shareholders stand to receive 590p per share in cash, with an additional 22p available through permitted dividends—dividends the company may issue ahead of completion without trimming the cash offer. That puts the total price tag for Schroders near 9.9 billion pounds. 3
That’s the math behind the screen price. Schroders’ dividend track record lays out a 15p final dividend lined up for 2025, with the shares going ex-dividend on March 12. The offer document also flagged a likely 7p interim payout for the first half of 2026. Shares have barely budged since—staying within a tight 570.5p to 573p band. 4
Nuveen made its move right as Schroders was turning the corner. Adjusted operating profit climbed 25% in 2025, hitting 756.6 million pounds, according to a Reuters report from Feb. 12. Morningstar’s Johann Scholtz labeled the offer “opportunistic,” arguing that with improved flows and margins, investors now have solid grounds to push for a higher price. 5
The reasoning behind the move is pretty simple. Reuters reported that together, the new entity would oversee around $2.5 trillion—still trailing BlackRock and Vanguard, and just under Amundi’s total in Europe. Schroders CEO Richard Oldfield called the merger a “powerhouse.” 6
Still, no one’s calling the spread a giveaway. J O Hambro, holding roughly 0.5% and ranked among the top 25 shareholders, argued back in February that Nuveen was priced 10%-15% under fair value. Portfolio managers at the firm pointed to the bid as evidence of just how undervalued UK equities remain. There are also hurdles ahead: the proposal hasn’t cleared shareholder votes, needs a court sign-off, and awaits regulatory approval. 7
Nuveen has locked in irrevocable commitments covering about 42% of Schroders’ issued share capital, the offer document shows—these come from the main shareholder group trustee companies plus Schroders directors. Next up: April 16 draws focus, with investors eyeing how fast the approvals land through Q4. 3
